HOLLISTER, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (TKNO), a leading producer of critical reagents for the research, discovery, development ...
This guide provides an in-depth exploration of the essential role plasmids play in biotechnology and genetic engineering. From foundational concepts to the complexities of high-throughput production, ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL), today announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The ...
MAINZ, Germany, February 2, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced construction completion of the Company’s first proprietary plasmid DNA manufacturing facility ...
The SK pharmteco group is now offering a standardized viral vector and plasmid manufacturing process to a global audience. The global approach can help customers move to batches for clinical trials in ...
- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...
Attractive cost of goods gives plasmid DNA commercial path forward and positions Kaneka Eurogentec as the premier supplier for plasmid DNA. Kaneka Eurogentec, an FDA inspected CDMO focused on the ...
TORONTO--(BUSINESS WIRE)--Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA for use in genetic medicines, announced today that they have formed a partnership with ...
An operator trained in GMP conditions is checking centrifugation parameters on the touchscreen of the device Attractive cost of goods gives plasmid DNA commercial path forward and positions Kaneka ...
MILAN, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer Company in immuno-oncology, and ANEMOCYTE, a leading provider of advanced therapy and nucleic acids solutions, today ...
After charting multiple personalized medicine expansions in recent years, contract manufacturer Charles River Laboratories is back with another gene therapy pact—this time centered on an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results